Cited by 783Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Open access

Haidet-Phillips, Amanda M, Hester, Mark E, Miranda, Carlos J, Meyer, Kathrin, Braun, Lyndsey, Frakes, Ashley, Song, SungWon, Likhite, Shibi, Murtha, Matthew J, Foust, Kevin D, Rao, Meghan, Eagle, Amy, Kammesheidt, Anja, Christensen, Ashley, Mendell, Jerry R, Burghes, Arthur H M, Kaspar, Brian K·2011·Nature Biotechnology

DOI 10.1038/nbt.1957PMC PMC3170425

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS. However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases. Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.1957

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Directed differentiation of embryonic stem cells into motor neurons.
Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00835-8 · Cited by 1,792
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“Recently, novel vectors have been shown to efficiently target astrocytes of adult brain and spinal cor”
BackgroundSelf-citation
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,131

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 501–600 of 783

CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
Dennys, C. N., Roussel, F. S., Rodrigo, R., Zhang, X., Sierra-Delgado, J. A., Hartlaub, A. M., Saelim‐Ector, A., Ray, W., Heintzman, S., Fox, A., et al. (2022) · Glia · doi:10.1002/glia.24278 · Cited by 19
Self-citation
GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment
Neha, N., Wali, Z., Pinky, P., Hattiwale, S. H., Jamal, A., & Parvez, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102134 · Cited by 19
Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1
Trippier, P. C., Benmohamed, R., Kirsch, D. R., & Silverman, R. B. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.114 · Cited by 19
Neural stem cells as tools for drug discovery: novel platforms and approaches
Gorba, T., & Conti, L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.805199 · Cited by 20
The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
Valsecchi, V., Boido, M., Montarolo, F., Guglielmotto, M., Perga, S., Martire, S., Cutrupi, S., Iannello, A., Gionchiglia, N., Signorino, E., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.043513 · Cited by 19
Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis
Aebischer, J., Bernard‐Marissal, N., Pettmann, B., & Raoul, C. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/746845 · Cited by 19
The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy – a perspective on cell biological mechanisms
Tang, B. L. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0018 · Cited by 20
A perspective on stem cell modeling of amyotrophic lateral sclerosis
de Boer, A. S., & Eggan, K. C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093712 · Cited by 19
An Engraftable Human Embryonic Stem Cell Neuronal Lineage-Specific Derivative Retains Embryonic Chromatin Plasticity for Scale-Up CNS Regeneration
Parsons, X. H. (2012) · journal of Regenerative Medicine and Tissue Engineering · doi:10.7243/2050-1218-1-3 · Cited by 17
Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis
Wang, X., Chen, W., Li, C., & Xu, R. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0010 · Cited by 18
Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis
Shijo, T., Warita, H., Suzuki, N., Ikeda, K., Mitsuzawa, S., Akiyama, T., Ono, H., Nishiyama, A., Izumi, R., Kitajima, Y., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.06.009 · Cited by 18
Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
Ban, J., Sámano, C., Mladinić, M., & Munitić, I. (2019) · Croatian Medical Journal · doi:10.3325/cmj.2019.60.109 · Cited by 20
Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review
Brito, M. D., da Silva, G. F. G., Tilieri, E. M., de Araujo, B. P. R., Calió, M. L., & Rosenstock, T. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01205 · Cited by 18
Amyotrophic lateral sclerosis and organ donation: Is there risk of disease transmission?
Holmes, B. B., & Diamond, M. I. (2012) · Annals of Neurology · doi:10.1002/ana.23684 · Cited by 18
Lipocalin‐2 is increased in amyotrophic lateral sclerosis
Petrozziello, T., Mills, A. N., Farhan, S. M. K., Mueller, K. A., Granucci, E. J., Glajch, K. E., Chan, J., Chew, S., Berry, J. D., & Sadri‐Vakili, G. (2020) · Muscle & Nerve · doi:10.1002/mus.26911 · Cited by 17
Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse
Spalloni, A., & Longone, P. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.006 · Cited by 19
An electrically resistive sheet of glial cells for amplifying signals of neuronal extracellular recordings
Matsumura, R., Yamamoto, H., Niwano, M., & Hirano‐Iwata, A. (2016) · Applied Physics Letters · doi:10.1063/1.4939629 · Cited by 17
Can Proprioceptive Training Reduce Muscle Fatigue in Patients With Motor Neuron Diseases? A New Direction of Treatment
Mohamed, A. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01243 · Cited by 17
Glia as primary drivers of neuropathology in TDP-43 proteinopathies
Sloan, S. A., & Barres, B. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301608110 · Cited by 17
Stem cell contributions to neurological disease modeling and personalized medicine
Liang, N., Trujillo, C. A., Negraes, P. D., Muotri, A. R., Lameu, C., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.025 · Cited by 18
Comparative effects of progesterone and the synthetic progestin norethindrone on neuroprotection in a model of spontaneous motoneuron degeneration
Gargiulo-Monachelli, G. M., Meyer, M., Lara, A., Garay, L. I., Lima, A. E., Roig, P., Nicola, A. F. D., & Deniselle, M. C. G. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105385 · Cited by 18
Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice
Liu, L., Killoy, K. M., Vargas, M. R., Yamamoto, Y., & Pehar, M. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.636 · Cited by 17
The use of human neurons for novel drug discovery in dementia research
Vargas‐Caballero, M., Willaime‐Morawek, S., Gómez‐Nicola, D., Perry, V. H., Bulters, D. O., & Mudher, A. K. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1154528 · Cited by 15
High content analysis in amyotrophic lateral sclerosis
Rinaldi, F., Motti, D., Ferraiuolo, L., & Kaspar, B. K. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.001 · Cited by 17
Self-citation
Emerging trends in IRAK-4 kinase research
Yadav, H. K., & Shirumalla, R. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08438-w · Cited by 15
Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons
Rojas, F., Aguilar, R., Almeida, S., Fritz, E., Corvalán, D., Ampuero, E., Abarzúa, S., Garcés, P., Amaro, A., Diaz, I., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1226604 · Cited by 15
Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models
Tang, J., Kang, Y., Zhou, Y., Chen, Q., Lan, J., Liu, X., & Peng, Y. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110760 · Cited by 16
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
Lee, S. Y., Cho, H.-Y., Oh, J.-P., Park, J., Bae, S.-H., Park, H., Kim, E. J., & Lee, J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01444-7 · Cited by 21
Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells
Selvaraj, B. T., Livesey, M. R., & Chandran, S. (2017) · Brain Pathology · doi:10.1111/bpa.12520 · Cited by 14
Pathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors
Ye, H., Ng, H. W., Sakkiah, S., Ge, W., Perkins, R., Tong, W., & Hong, H. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13040373 · Cited by 15
Pathophysiology of Amyotrophic Lateral Sclerosis
Fabian, H., Clara, M., & Alvaro, G. (2013) · InTech eBooks · doi:10.5772/56562 · Cited by 17
EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytes
Dennys, C. N., Baggio, C., Rodrigo, R., Roussel, F. S., Kulinich, A. O., Heintzman, S., Fox, A., Kolb, S. J., Shaw, P. J., Ethell, I. M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104877 · Cited by 16
Self-citation
Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes
Lu, J., He, A.-X., Jin, Z.-Y., Zhang, M., Li, Z., Zhou, F., Ma, L., Jin, H.-M., Wang, J., & Shen, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01223-2 · Cited by 14
Could an Impairment in Local Translation of mRNAs in Glia be Contributing to Pathogenesis in ALS?
Barton, S. K., Gregory, J. M., Chandran, S., & Turner, B. J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00124 · Cited by 18
Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
Stein, E. S., Rahal, I. A., Bushi, D., Gera, O., Sharon, R., Gofrit, S. G., Pollak, L., Mindel, E., Maggio, N., Kloog, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103419 · Cited by 14
The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis
Goursaud, S., Schäfer, S., Dumont, A. O., Vergouts, M., Gallo, A., Desmet, N., Deumens, R., & Hermans, E. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.022 · Cited by 15
Basics of Stem Cell Biology as Applied to the Brain
Tabansky, I., & Stern, J. N. H. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_2 · Cited by 14
Boundary Cap Neural Crest Stem Cells Promote Survival of Mutant SOD1 Motor Neurons
Aggarwal, T., Hoeber, J., Ivert, P., Vasylovska, S., & Kozlova, E. N. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0505-8 · Cited by 14
Structural switching of Cu,Zn-superoxide dismutases at loop VI: insights from the crystal structure of 2-mercaptoethanol-modified enzyme
Ihara, K., Fujiwara, N., Yamaguchi, Y., Torigoe, H., Soichi Wakatsuki, A., Taniguchi, N., & Suzuki, K. (2012) · Bioscience Reports · doi:10.1042/bsr20120029 · Cited by 14
Astrocytic TGF-β1: detrimental factor in ALS
Endo, F., & Yamanaka, K. (2015) · Oncotarget · doi:10.18632/oncotarget.4786 · Cited by 14
In Vitro Models of Amyotrophic Lateral Sclerosis
Zhou, L., Chen, W., Jiang, S., & Xu, R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01423-8 · Cited by 13
Experimental Advances Towards Neural Regeneration from Induced Stem Cells to Direct In Vivo Reprogramming
Dametti, S., Faravelli, I., Ruggieri, M., Ramirez, A., Nizzardo, M., & Corti, S. P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9181-7 · Cited by 13
Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
Rossi, S., & Cozzolino, M. (2021) · Cells · doi:10.3390/cells10113005 · Cited by 15
Astrocyte‐targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast‐fatigable motor units in a mouse model of amyotrophic lateral sclerosis
Rochat, C., Bernard‐Marissal, N., Källstig, E., Pradervand, S., Perrin, F. E., Aebischer, P., Raoul, C., & Schneider, B. L. (2022) · Glia · doi:10.1002/glia.24140 · Cited by 13
Potential of astrocytes in targeting therapy for Alzheimer’s disease
Bi, W., Lei, T., Cai, S., Zhang, X., Yang, Y., Xiao, Z., Wang, L., & Du, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109368 · Cited by 13
Is amyotrophic lateral sclerosis a primary astrocytic disease?
Sica, R. E. P. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.036 · Cited by 13
SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis
Wallis, N., Lau, C. L., Farg, M. A., Atkin, J. D., Beart, P. M., & O’Shea, R. D. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2385-7 · Cited by 14
Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges
Brüge, A., Ponimaskin, E. G., & Labus, J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100071 · Cited by 13
Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases
Deng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 14
The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Houghton, O. H., Mizielinska, S., & Gómez‐Suaga, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838402 · Cited by 12
Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials
Nejad, L. D., & Pioro, E. P. (2025) · Brain Sciences · doi:10.3390/brainsci15020134 · Cited by 13
Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1)
Surrey, V., Zoeller, C., Lork, A. A., Moradi, M., Balk, S., Dombert, B., Saal-Bauernschubert, L., Briese, M., Appenzeller, S., Fischer, U., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.019 · Cited by 12
Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model
Stella, R., Bonadio, R. S., Cagnin, S., Massimino, M. L., Bertoli, A., & Peggion, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137028 · Cited by 12
Models for IGHMBP2-associated diseases: an overview and a roadmap for the future
Rzepnikowska, W., & Kochański, A. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.08.001 · Cited by 12
NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons
Killoy, K. M., Harlan, B. A., Pehar, M., & Vargas, M. R. (2022) · The FASEB Journal · doi:10.1096/fj.202101275r · Cited by 12
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13
A High-throughput and Pathophysiologically Relevant Astrocyte-motor Neuron Co-culture Assay for Amyotrophic Lateral Sclerosis Therapeutic Discovery
Stopford, M. J., Allen, S. P., & Ferraiuolo, L. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3353 · Cited by 11
The potential role of misfolded wild-type SOD1 protein in sporadic amyotrophic lateral sclerosis (ALS): a review of the evidence
Marlow, T. R., Bowden, K. M., Collins, M. O., & Shaw, P. J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107124 · Cited by 12
Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases
Volonté, C., Hu, G., Shaw, C. A., Claudio, V. J., dos Santos, J. A., Vaz, S. H., Sebastião, A. M., Balcar, V. J., Mozley, P. D., Verde, F., et al. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004136 · Cited by 12
Pyruvate dehydrogenase kinase 2 knockdown restores the ability of amyotrophic lateral sclerosis ‐linked SOD1G93A rat astrocytes to support motor neuron survival by increasing mitochondrial respiration
Miquel, E., Villarino, R., Palma, L. M., Cassina, A., & Cassina, P. (2024) · Glia · doi:10.1002/glia.24516 · Cited by 11
Postactivation depression of the Ia EPSP in motoneurons is reduced in both the G127X SOD1 model of amyotrophic lateral sclerosis and in aged mice
Hedegaard, A., Lehnhoff, J., Moldovan, M., Grøndahl, L., Petersen, N., & Meehan, C. F. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00745.2014 · Cited by 11
Quo vadis motor neuron disease?
Balendra, R., & Patani, R. (2016) · World Journal of Methodology · doi:10.5662/wjm.v6.i1.56 · Cited by 11
Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice
Obál, I., Klausz, G., Mándi, Y., Deli, M. A., Siklós, L., & Engelhardt, J. I. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0586-7 · Cited by 11
Regional differences in the inflammatory and heat shock response in glia: implications for ALS
Clarke, B. E., Gil, R. S., Yip, J., Kalmár, B., & Greensmith, L. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01005-y · Cited by 11
Glial-restricted precursors as potential candidates for ALS cell-replacement therapy
Kruminis-Kaszkiel, E., Wojtkiewicz, J., & Maksymowicz, W. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1989 · Cited by 11
Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors
Николаевна, В. М., Yen, L. Y., Khmyz, M. I., Sobolevsky, A. I., & Yelshanskaya, M. V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1252953 · Cited by 9
Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1
Pokrishevsky, E., DuVal, M. G., McAlary, L., Louadi, S., Pozzi, S., Roman, A. Y., Plotkin, S. S., Dijkstra, A. A., Julien, J., Allison, W. T., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107207 · Cited by 12
Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death
Martínez, P., Silva, M., Abarzúa, S., Tevy, M. F., Jaimovich, E., Constantine‐Paton, M., Bustos, F. J., & van Zundert, B. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00942-4 · Cited by 13
Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model
Jin, S., Tian, Y., Hacker, J., Chen, X., Bertolio, M., Reynolds, C. R., Jarvis, R., Hu, J., Promes, V., Halim, D. O., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3350 · Cited by 10
Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design Considerations
Quigley, S., Quigg, K. H., & Goutman, S. A. (2025) · CNS Drugs · doi:10.1007/s40263-025-01217-0 · Cited by 10
Neurodegenerative diseases
Verkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00012-2 · Cited by 10
Glial-restricted progenitor cells: a cure for diseased brain?
Rogujski, P., Łukomska, B., Janowski, M., & Stanaszek, L. (2024) · Biological Research · doi:10.1186/s40659-024-00486-1 · Cited by 12
Amyotrophic Lateral Sclerosis: Current Therapeutic Perspectives
Kumar, V., Kashav, T., & Hassan, M. I. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_19 · Cited by 10
NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands
Baggio, C., Kulinich, A. O., Dennys, C. N., Rodrigo, R., Meyer, K., Ethell, I. M., & Pellecchia, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00608 · Cited by 10
Self-citation
Why do motor neurons degenerate? Actualisation in the pathogenesis of amyotrophic lateral sclerosis
Riancho, J., Gonzalo, I., Ruiz‐Soto, M., & Berciano, J. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.12.019 · Cited by 11
Superoxide Dismutase and Oxidative Stress in Amyotrophic Lateral Sclerosis
Clara, M., Cassandra, N., Fabian, H., & Alvaro, G. (2013) · InTech eBooks · doi:10.5772/56488 · Cited by 10
Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
Carreras, F. J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.191211 · Cited by 10
ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation
Allison, R. L., & Ebert, A. D. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad209 · Cited by 9
Dynamic properties of SOD1 mutants can predict survival time of patients carrying familial amyotrophic lateral sclerosis
Alemasov, N. A., Ivanisenko, N. V., Medvedev, S. P., Zakian, S. M., Kolchanov, N. A., & Иванисенко, В. А. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1158666 · Cited by 9
Astrocyte-based cell therapy: new hope for amyotrophic lateral sclerosis patients?
Barbeito, L. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1006-y · Cited by 9
Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
García‐Domínguez, M. (2025) · Life · doi:10.3390/life15101498 · Cited by 12
Targeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes
Zheng, Z., Yang, W., Chen, Z., Chen, P., Tao, M., Wang, S., Cui, B., Yang, Z., Yan, Y., Han, X., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.003 · Cited by 9
SOD1-targeting therapies for neurodegenerative diseases: a review of current findings and future potential
Franklin, J., Azzouz, M., & Shaw, P. J. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1835638 · Cited by 8
Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosis
Olivera‐Bravo, S., Bolatto, C., Damianovich, G. O., Stancov, M., Cerri, S., Rodríguez, P., Boragno, D., Mir, K. H., Cuitiño, M. N., Larrambembere, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06470-7 · Cited by 9
IFNγ protects motor neurons from oxidative stress via enhanced global protein synthesis in FUS ‐associated amyotrophic lateral sclerosis
Assoni, A. F., Guerrero, E. N., Wardenaar, R., Oliveira, D., Bakker, P. L., Alves, L. M., Carvalho, V. M., Okamoto, O. K., Zatz, M., & Foijer, F. (2023) · Brain Pathology · doi:10.1111/bpa.13206 · Cited by 8
Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis
Lv, Y.-T., & Li, H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00286 · Cited by 8
Astrocytic NF‐κB brings the best and worst out of microglia
Dokalis, N., & Prinz, M. (2018) · The EMBO Journal · doi:10.15252/embj.2018100130 · Cited by 9
Making Sense of Pain: Are Pluripotent Stem Cell–derived Sensory Neurons a New Tool for Studying Pain Mechanisms?
Meyer, K., & Kaspar, B. K. (2014) · Molecular Therapy · doi:10.1038/mt.2014.123 · Cited by 8
Self-citation
The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytes
Milosevic, M. M., Bataveljić, D., Nikolic, L. M., Bijelić, D. D., & Anđjus, P. R. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1143516 · Cited by 8
Patient‐derived olfactory mucosa for study of the non‐neuronal contribution to amyotrophic lateral sclerosis pathology
García‐Escudero, V., Rosales, M., Muñoz, J. L., Scola, E., Medina, J., Khalique, H., Garaulet, G., Rodrı́guez, A., & Lim, F. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12488 · Cited by 8
The familial amyotrophic lateral sclerosis-associated A4V SOD1 mutant is not able to regulate aerobic glycolysis
Paranhos, L. H., Magalhães, R. S. S., Brasil, A. D. A., Neto, J. R. M., Ribeiro, G. D., Queiroz, D. D., dos Santos, V. M., & Eleuthério, E. C. A. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130634 · Cited by 7
Deciphering the spectrum of astrocyte diversity: Insights into molecular, morphological, and functional dimensions in health and neurodegenerative diseases
Endo, F. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.07.008 · Cited by 8
Can Astrocytes Be a Target for Precision Medicine?
Allen, C. F., Shaw, P. J., & Ferraiuolo, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_7 · Cited by 7
Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5
Arnoux, A., & Dupuis, L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103149 · Cited by 7
Selective Vulnerability of Neuronal Subtypes in ALS: A Fertile Ground for the Identification of Therapeutic Targets
Rochat, C., Bernard‐Marissal, N., & Schneider, B. L. (2016) · InTech eBooks · doi:10.5772/63703 · Cited by 8
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment
Berezovsky, A. D., Nuga, O., Datta, I., Bergman, K., Sabedot, T. S., Gurdziel, K., Irtenkauf, S. M., Hasselbach, L. A., Meng, Y., Mueller, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315171 · Cited by 8
Astrocytes Contribute to Motor Neuron Degeneration in ALS via the TRAIL ‐ DR5 Signaling Pathway
Yang, K., Liu, Y., Deng, W., Gong, Z., Huang, L., Li, Z., & Zhang, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70146 · Cited by 6
Pathophysiological Correlation between Cigarette Smoking and Amyotrophic Lateral Sclerosis
Menounos, S., Hansbro, P. M., Diwan, A. D., & Das, A. (2021) · NeuroSci · doi:10.3390/neurosci2020008 · Cited by 6
The Essential Role of Astrocytes in Neurodegeneration and Neuroprotection
Couselo, F. L., Saba, J., Carniglia, L., Durand, D., Lasaga, M., & Caruso, C. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273269881231012062255 · Cited by 6
Amyotrophic Lateral Sclerosis: Focus on Cytoplasmic Trafficking and Proteostasis
Shrilaxmi, M. S., Banerjee, S., D’Mello, S. R., & Dastidar, S. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04831-7 · Cited by 6

Authors: Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J. R., Burghes, A. H. M., & Kaspar, B. K.
Affiliations: Nationwide Children's Hospital (US)
Ambry Genetics (United States) (US)
The Ohio State University (US)
Corresponding author: Kaspar, Brian K
ORCID: Hester, Mark E
Miranda, Carlos J
Meyer, Kathrin
Likhite, Shibi
Foust, Kevin D
Mendell, Jerry R
Burghes, Arthur H M
Kaspar, Brian K
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2011-08-10
Volume: 29
Issue: 9
Pages: 824-828
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.1957
PMC: PMC3170425
OpenAlex: W2059355164
Cited by: 782
References: 30
Citations by year: 2026: 21 · 2025: 29 · 2024: 43 · 2023: 38 · 2022: 54 · 2021: 46 · 2020: 68 · 2019: 59 · 2018: 55 · 2017: 58 · 2016: 66 · 2015: 59 · 2014: 70 · 2013: 59 · 2012: 50
FWCI: 37.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (RC2NS069476, R01 NS644912-1A1, RC2 NS69476-01, R01NS064492, T32NS077984, F31NS058224)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: amyotrophic lateral sclerosis, astrocytes, motor neuron toxicity, sporadic ALS, familial ALS, SOD1, disease mechanisms
MeSH terms: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Cell Differentiation, Cell Line, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Motor Neurons, Mutation, Superoxide Dismutase, Signal Transduction, Biomarkers, Sequence Analysis, DNA, Coculture Techniques, Mice, Embryonic Stem Cells, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks